Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyGeisinger Health Plan Zynteglo Prior Auth Form | O…
    Ask Trek AI about this page
    CurrentGeisinger Health PlanPolicy N/A

    ZYNTEGLO (betibeglogene autotemcel) PRIOR AUTHORIZATION FORM

    Customize your policy alerts

    Sign up for all Geisinger Health Plan policy alerts

    Know when Geisinger Health Plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document is a prior authorization form and instructions for requesting coverage of Zynteglo for Geisinger Health Plan beneficiaries; it affects prescribers, billing providers, and plan beneficiaries seeking authorization for Zynteglo.

    Policy Summary
    PayerGeisinger Health Plan
    PolicyZYNTEGLO (betibeglogene autotemcel) PRIOR AUTHORIZATION FORM
    Policy CodePolicy N/A
    Change TypeAdministrative — form/instructions
    Effective DateJul 15, 2024
    Next Review DateN/A
    Key ActionSubmit the completed prior authorization form with required clinical documentation via PromptPA or fax to 570-271-5610.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    7/15/2024form effective date
    prior authauthorization type
    570-271-5610fax
    PromptPAportal

    Authorization Criteria for Zynteglo

    Authorization criteria

    Covered when ALL of the following are met:

    ALL of the following

    • Prescriber confirms beneficiary has NOT received prior gene therapy.

      Form includes checkbox to confirm beneficiary has NOT received prior gene therapy; submit supporting documentation (e.g., chart/clinic notes).

    • Prescriber confirms beneficiary has NOT received a prior allogeneic hematopoietic stem cell transplant (HSCT).

      Form includes checkbox to confirm no prior allogeneic HSCT; submit supporting documentation.

    • Genetic testing confirming the diagnosis of β‑thalassemia is provided.

      Form includes checkbox for genetic testing; submit the genetic test results.

    Policy Summary
    PayerGeisinger Health Plan
    PolicyZYNTEGLO (betibeglogene autotemcel) PRIOR AUTHORIZATION FORM
    Policy CodePolicy N/A
    Change TypeAdministrative — form/instructions
    Effective DateJul 15, 2024
    Next Review DateN/A
    Key ActionSubmit the completed prior authorization form with required clinical documentation via PromptPA or fax to 570-271-5610.
    SourceLink
    On This Page
    Authorization Criteria for ZyntegloDiagnosis and Related CodingSubmission Instructions and Required AttestationsDrug and Term Definitions

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Transfusion burden meets threshold: history of at least 100 mL/kg/year OR at least 8 packed red blood cell transfusion episodes per year, documented over the prior 2 years.

    Must submit transfusion history documentation (e.g., transfusion records, clinic notes).

  1. Diagnosis code (DX code) provided on the form.

    DX code is required on the form; include supporting diagnostic documentation and test results.

  2. Prescriber completes beneficiary and prescriber information, signs and dates the form, and submits the completed form with required clinical documentation.

    Submission options: PromptPA portal (https://ghp.promptpa.com) or fax to Geisinger Health Plan at 570-271-5610.

  3. Diagnosis and Related Coding

    Diagnosis codingICD-10
    Diagnosis code (DX code) required on form; no specific ICD-10 code listed on form.
    Transfusion history threshold — documentation required
    Transfusion volume thresholdHistory of at least 100 mL/kg/year of packed red blood cell transfusions in the prior 2 years (documentation required)
    Transfusion episode thresholdHistory of at least 8 transfusion episodes/year of packed red blood cell transfusions in the prior 2 years (documentation required)
    Time window for documentationPrior 2 years from date of request — submit supporting transfusion records or clinic notes
    Required supporting documentationRecent chart/clinic notes, transfusion logs, diagnostic evaluations, or test results demonstrating transfusion history

    Submission Instructions and Required Attestations

    Prior Authorization

    Submit completed prior authorization form with required clinical documentation

    Submit the completed prior authorization form along with required clinical documentation (recent chart/clinic notes, diagnostic evaluations, test results). Submission options: use the PromptPA portal (https://ghp.promptpa.com) or fax the completed form and supporting records to Geisinger Health Plan at 570-271-5610.

    • Include recent chart/clinic notes, diagnostic evaluations, and relevant test results.
    • Submit via PromptPA: https://ghp.promptpa.com or fax to 570-271-5610.
    Documentation Required

    Prescriber attestation and required documentation (genetic testing, transplant/gene therapy status, transfusion history)

    The prescriber must complete beneficiary and prescriber information on the form, attest that the beneficiary has not received prior gene therapy or a prior allogeneic hematopoietic stem cell transplant, confirm genetic testing that diagnoses β‑thalassemia, provide transfusion history, and sign and date the form.

    • Complete beneficiary and prescriber identifying information (name, ID, DOB, prescriber NPI, contact details).
    • Attest that the beneficiary has NOT received prior gene therapy and has NOT received a prior allogeneic hematopoietic stem cell transplant.
    • Provide genetic testing confirming diagnosis of β‑thalassemia and documentation of transfusion history (≥100 mL/kg/year or ≥8 transfusion episodes/year over the prior 2 years).
    • Sign and date the form.

    Drug and Term Definitions

    Drug name
    Generic namebetibeglogene autotemcel
    Brand nameZynteglo
    Form contextListed as the requested drug name on the Geisinger Health Plan prior authorization form